Skip to main content

Cuffe Michael S.'s Form 4 filing

HCA Healthcare, Inc. (HCA) · filed May 8, 2024

Accession no.
0001209191-24-005570
Filed
May 8, 2024
Trade date
May 6-8, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $494.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cuffe Michael S.CIK 0001632835Officer (EVP and Chief Clinical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 6, 2024Common StockSSaleDisposed−1,600$309.00−$494,40034,123.97Direct
May 7, 2024Common StockMOption exerciseAcquired+18,660$139.06+$2,594,859.652,783.97Direct
May 7, 2024Common StockFTax withholdingDisposed−12,349$314.45−$3,883,143.0540,434.97Direct
May 8, 2024Common StockGGiftDisposed−4,500$0.00$035,934.97Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 7, 2024Common StockMOption exerciseDisposed−18,660$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)